Glaxo Smith Kline: The Salford Lung Study
Glaxo Smith Kline is a global healthcare company that researches, develops and manufactures innovative pharmaceutical medicines, vaccines and consumer healthcare products.
The Salford Lung Study was an innovative ‘real-world’ research project studying the safety and effectiveness of a Glaxo Smith Kline respiratory medicine alongside currently available treatments.
The study was a unique collaboration between Glaxo Smith Kline, North West e-Health, The University of Manchester, Salford Royal NHS Foundation Trust, NHS Salford, local GPs and local community pharmacists.
It was the first large, prospective, ‘real-world’ study to be conducted within one geographical setting and was initiated before the medicine was licensed.
We worked with Glaxo Smith Kline and Mirrorworld Technologies to develop a unique Salford Lung Study visualisation platform that was used to demonstrate the study to audiences worldwide.
The platform featured a virtual model of the City of Salford over which social, health and study data could be displayed and interacted with.
The innovative platform was used in a variety of ways to introduce Salford as a city to international audiences, tell the unique ‘story’ of the study and help illustrate the journey of a patient involved in the study.
Going forward the base platform provides the functionality to create and display a range of social and health perspectives of the city and we are working closely with the Salford Lung Study team to integrate additional data and create a range of interactive study scenarios.